The impact of pharmacogenetics and pharmacogenomics on drug discovery
- 1 June 2002
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 1 (6) , 463-469
- https://doi.org/10.1038/nrd823
Abstract
It is widely perceived at present that pharmacogenetics and pharmacogenomics are about to revolutionize the face of medicine. In a more realistic assessment, the implementation of molecular genetics and biology will provide us with better ways to treat illnesses, and has already begun to do so in an incremental and evolutionary fashion. However, it is unlikely to change fundamentally the direction of medical progress. Advances are most likely to be made in the area of pharmacodynamics, as we learn to differentiate broader conventional clinical diagnoses into separate molecular subtypes.Keywords
This publication has 20 references indexed in Scilit:
- Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatmentNature Genetics, 1999
- Not quite pharmacogenomicsNature Biotechnology, 1998
- Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression.Journal of Clinical Investigation, 1998
- HIV-1 infection in an individual homozygous for CCR5▵32The Lancet, 1997
- HIV-1 infection in a man homozygous for CCR5▵32The Lancet, 1997
- Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.Journal of Clinical Investigation, 1997
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.Journal of Clinical Oncology, 1996